DOCSLIB.ORG

Mouse Sesn3 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Sesn3 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Sesn3 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Sesn3 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Sesn3 gene (NCBI Reference Sequence: NM_030261 ; Ensembl: ENSMUSG00000032009 ) is located on Mouse chromosome 9. 10 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 10 (Transcript: ENSMUST00000208222). Exon 5~6 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Sesn3 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-250B9 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: When fed a high fat diet, mice homozygous for a gene trap allele exhibit impaired glucose tolerance, insulin resistance, reduced hepatic glucose production, impaired adipocyte glucose uptake, increased hepatic steatosis, and decreased mitochondria in the liver. Exon 5 starts from about 35.64% of the coding region. The knockout of Exon 5~6 will result in frameshift of the gene. The size of intron 4 for 5'-loxP site insertion: 4065 bp, and the size of intron 6 for 3'-loxP site insertion: 4054 bp. The size of effective cKO region: ~2245 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 5 6 10 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Sesn3 Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(8745bp) | A(28.87% 2525) | C(19.81% 1732) | T(29.15% 2549) | G(22.17% 1939) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr9 + 14311247 14314246 3000 browser details YourSeq 176 610 2116 3000 87.1% chr10 + 48438144 48479589 41446 browser details YourSeq 133 699 2116 3000 93.5% chr1 - 60948472 61348692 400221 browser details YourSeq 120 247 748 3000 77.5% chr13 - 96696134 96696296 163 browser details YourSeq 117 1998 2136 3000 89.2% chr1 + 192751950 192752080 131 browser details YourSeq 116 586 753 3000 87.8% chr1 - 60015450 60015617 168 browser details YourSeq 115 1998 2136 3000 89.9% chr1 - 152056399 152056530 132 browser details YourSeq 114 1998 2135 3000 92.0% chr18 + 21614639 21614796 158 browser details YourSeq 113 1998 2136 3000 93.9% chrX - 118775592 118775732 141 browser details YourSeq 112 244 752 3000 74.2% chr1 - 110857934 110858127 194 browser details YourSeq 111 247 752 3000 75.9% chr4 + 120818924 120819083 160 browser details YourSeq 110 1998 2137 3000 90.6% chr1 - 123538786 123538923 138 browser details YourSeq 109 2003 2118 3000 97.4% chrX - 41877080 41877197 118 browser details YourSeq 109 1998 2119 3000 95.1% chr2 + 23809420 23809543 124 browser details YourSeq 109 1998 2117 3000 95.8% chr11 + 12277194 12277315 122 browser details YourSeq 109 1998 2130 3000 91.7% chr10 + 49965983 49966127 145 browser details YourSeq 106 1998 2121 3000 95.0% chr1 - 83452687 83452810 124 browser details YourSeq 105 1998 2115 3000 96.5% chr9 + 66401762 66401880 119 browser details YourSeq 103 610 752 3000 87.2% chr1 - 36488959 36489103 145 browser details YourSeq 102 1998 2116 3000 91.5% chr1 + 46530305 46530422 118 Note: The 3000 bp section upstream of Exon 5 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr9 + 14316492 14319491 3000 browser details YourSeq 126 903 1609 3000 83.8% chr10 - 122980054 122996129 16076 browser details YourSeq 105 938 1598 3000 89.6% chr11 - 101454166 101638847 184682 browser details YourSeq 89 1475 1604 3000 87.7% chr1 - 180879595 180879724 130 browser details YourSeq 87 1475 1600 3000 85.6% chr11 + 120802298 120802422 125 browser details YourSeq 85 1481 1609 3000 92.2% chr1 - 21338671 21338799 129 browser details YourSeq 83 1475 1612 3000 88.5% chr1 + 168744800 168744936 137 browser details YourSeq 82 1473 1609 3000 86.7% chr2 - 94507944 94508079 136 browser details YourSeq 79 1481 1609 3000 82.6% chr10 - 92394165 92394287 123 browser details YourSeq 78 774 979 3000 80.2% chr12 + 110354385 110354578 194 browser details YourSeq 76 870 979 3000 86.6% chr11 + 64444885 64444996 112 browser details YourSeq 75 1475 1608 3000 86.0% chr7 - 5676960 5677092 133 browser details YourSeq 70 1475 1598 3000 85.8% chr18 - 16581320 16581443 124 browser details YourSeq 70 1475 1564 3000 89.2% chr11 - 117448760 117448847 88 browser details YourSeq 67 1475 1604 3000 86.6% chr13 - 35596934 35597061 128 browser details YourSeq 67 1475 1588 3000 83.4% chr16 + 90214589 90214701 113 browser details YourSeq 66 794 987 3000 92.3% chr6 - 144989269 144989704 436 browser details YourSeq 65 1473 1609 3000 76.2% chr2 - 39127846 39127979 134 browser details YourSeq 65 1517 1612 3000 89.4% chr11 - 117961331 117961424 94 browser details YourSeq 65 1513 1609 3000 90.2% chr1 - 141575211 141575664 454 Note: The 3000 bp section downstream of Exon 6 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: Sesn3 sestrin 3 [ Mus musculus (house mouse) ] Gene ID: 75747, updated on 12-Aug-2019 Gene summary Official Symbol Sesn3 provided by MGI Official Full Name sestrin 3 provided by MGI Primary source MGI:MGI:1922997 See related Ensembl:ENSMUSG00000032009 Gene type protein coding RefSeq status PROVISIONAL Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as SEST3; BC003348; 5630400E15Rik Expression Ubiquitous expression in ovary adult (RPKM 13.1), thymus adult (RPKM 11.0) and 28 other tissues See more Orthologs human all Genomic context Location: 9; 9 A1 See Sesn3 in Genome Data Viewer Exon count: 10 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 9 NC_000075.6 (14276301..14326134) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 9 NC_000075.5 (14080745..14130578) Chromosome 9 - NC_000075.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 7 transcripts Gene: Sesn3 ENSMUSG00000032009 Description sestrin 3 [Source:MGI Symbol;Acc:MGI:1922997] Gene Synonyms 5630400E15Rik, SEST3 Location Chromosome 9: 14,275,067-14,333,101 forward strand. GRCm38:CM001002.2 About this gene This gene has 7 transcripts (splice variants), 203 orthologues, 2 paralogues, is a member of 1 Ensembl protein family and is associated with 3 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Sesn3-204 ENSMUST00000208222.1 9125 492aa ENSMUSP00000146362.1 Protein coding CCDS22820 A2RSF4 Q9CYP7 TSL:1 GENCODE basic APPRIS P1 Sesn3-201 ENSMUST00000034507.8 1827 414aa ENSMUSP00000034507.8 Protein coding - A0A0J9YMZ5 TSL:5 GENCODE basic Sesn3-207 ENSMUST00000209187.1 1700 353aa ENSMUSP00000146784.1 Protein coding - A0A140LIE1 TSL:5 GENCODE basic Sesn3-206 ENSMUST00000209145.1 4178 No protein - Retained intron - - TSL:NA Sesn3-203 ENSMUST00000208142.1 1915 No protein - Retained intron - - TSL:NA Sesn3-202 ENSMUST00000207207.1 714 No protein - Retained intron - - TSL:5 Sesn3-205 ENSMUST00000209106.1 505 No protein - lncRNA - - TSL:5 78.03 kb Forward strand 14.28Mb 14.30Mb 14.32Mb 14.34Mb Genes (Comprehensive set... Sesn3-207 >protein coding Gm47326-201 >lncRNA Sesn3-201 >protein coding Sesn3-204 >protein coding Sesn3-205 >lncRNA Sesn3-203 >retained intron Sesn3-202 >retained intron Sesn3-206 >retained intron Contigs < AC154264.2 CT485606.7 > Regulatory Build 14.28Mb 14.30Mb 14.32Mb 14.34Mb Reverse strand 78.03 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding processed transcript RNA gene Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000208222 56.80 kb Forward strand Sesn3-204 >protein coding ENSMUSP00000146... Low complexity (Seg) Coiled-coils (Ncoils) Superfamily AhpD-like Pfam Sestrin PANTHER Sestrin PTHR12474:SF4 Gene3D AhpD-like All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 60 120 180 240 300 360 420 492 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Load more

Recommended publications
  • S41419-021-03972-6.Pdf
    www.nature.com/cddis ARTICLE OPEN Primed to die: an investigation of the genetic mechanisms underlying noise-induced hearing loss and cochlear damage in homozygous Foxo3-knockout mice ✉ Holly J. Beaulac1,3, Felicia Gilels1,4, Jingyuan Zhang1,5, Sarah Jeoung2 and Patricia M. White 1 © The Author(s) 2021 The prevalence of noise-induced hearing loss (NIHL) continues to increase, with limited therapies available for individuals with cochlear damage. We have previously established that the transcription factor FOXO3 is necessary to preserve outer hair cells (OHCs) and hearing thresholds up to two weeks following mild noise exposure in mice. The mechanisms by which FOXO3 preserves cochlear cells and function are unknown. In this study, we analyzed the immediate effects of mild noise exposure on wild-type, Foxo3 heterozygous (Foxo3+/−), and Foxo3 knock-out (Foxo3−/−) mice to better understand FOXO3’s role(s) in the mammalian cochlea. We used confocal and multiphoton microscopy to examine well-characterized components of noise-induced damage including calcium regulators, oxidative stress, necrosis, and caspase-dependent and caspase-independent apoptosis. Lower immunoreactivity of the calcium buffer Oncomodulin in Foxo3−/− OHCs correlated with cell loss beginning 4 h post-noise exposure. Using immunohistochemistry, we identified parthanatos as the cell death pathway for OHCs. Oxidative stress response pathways were not significantly altered in FOXO3’s absence. We used RNA sequencing to identify and RT-qPCR to confirm differentially expressed genes. We further investigated a gene downregulated in the unexposed Foxo3−/− mice that may contribute to OHC noise susceptibility. Glycerophosphodiester phosphodiesterase domain containing 3 (GDPD3), a possible endogenous source of lysophosphatidic acid (LPA), has not previously been described in the cochlea.
    [Show full text]
  • Transcriptomic Causal Networks Identified Patterns of Differential Gene Regulation in Human Brain from Schizophrenia Cases Versus Controls
    Transcriptomic Causal Networks identified patterns of differential gene regulation in human brain from Schizophrenia cases versus controls Akram Yazdani1, Raul Mendez-Giraldez2, Michael R Kosorok3, Panos Roussos1,4,5 1Department of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA 2Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, NC, USA 3Department of Biostatistics, University of North Carolina at Chapel Hill, NC, USA 4Department of Psychiatry and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 5Mental Illness Research Education and Clinical Center (MIRECC), James J. Peters VA Medical Center, Bronx, New York, 10468, USA Abstract Common and complex traits are the consequence of the interaction and regulation of multiple genes simultaneously, which work in a coordinated way. However, the vast majority of studies focus on the differential expression of one individual gene at a time. Here, we aim to provide insight into the underlying relationships of the genes expressed in the human brain in cases with schizophrenia (SCZ) and controls. We introduced a novel approach to identify differential gene regulatory patterns and identify a set of essential genes in the brain tissue. Our method integrates genetic, transcriptomic, and Hi-C data and generates a transcriptomic-causal network. Employing this approach for analysis of RNA-seq data from CommonMind Consortium, we identified differential regulatory patterns for SCZ cases and control groups to unveil the mechanisms that control the transcription of the genes in the human brain. Our analysis identified modules with a high number of SCZ-associated genes as well as assessing the relationship of the hubs with their down-stream genes in both, cases and controls.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • Supplementary Table 1 Double Treatment Vs Single Treatment
    Supplementary table 1 Double treatment vs single treatment Probe ID Symbol Gene name P value Fold change TC0500007292.hg.1 NIM1K NIM1 serine/threonine protein kinase 1.05E-04 5.02 HTA2-neg-47424007_st NA NA 3.44E-03 4.11 HTA2-pos-3475282_st NA NA 3.30E-03 3.24 TC0X00007013.hg.1 MPC1L mitochondrial pyruvate carrier 1-like 5.22E-03 3.21 TC0200010447.hg.1 CASP8 caspase 8, apoptosis-related cysteine peptidase 3.54E-03 2.46 TC0400008390.hg.1 LRIT3 leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 1.86E-03 2.41 TC1700011905.hg.1 DNAH17 dynein, axonemal, heavy chain 17 1.81E-04 2.40 TC0600012064.hg.1 GCM1 glial cells missing homolog 1 (Drosophila) 2.81E-03 2.39 TC0100015789.hg.1 POGZ Transcript Identified by AceView, Entrez Gene ID(s) 23126 3.64E-04 2.38 TC1300010039.hg.1 NEK5 NIMA-related kinase 5 3.39E-03 2.36 TC0900008222.hg.1 STX17 syntaxin 17 1.08E-03 2.29 TC1700012355.hg.1 KRBA2 KRAB-A domain containing 2 5.98E-03 2.28 HTA2-neg-47424044_st NA NA 5.94E-03 2.24 HTA2-neg-47424360_st NA NA 2.12E-03 2.22 TC0800010802.hg.1 C8orf89 chromosome 8 open reading frame 89 6.51E-04 2.20 TC1500010745.hg.1 POLR2M polymerase (RNA) II (DNA directed) polypeptide M 5.19E-03 2.20 TC1500007409.hg.1 GCNT3 glucosaminyl (N-acetyl) transferase 3, mucin type 6.48E-03 2.17 TC2200007132.hg.1 RFPL3 ret finger protein-like 3 5.91E-05 2.17 HTA2-neg-47424024_st NA NA 2.45E-03 2.16 TC0200010474.hg.1 KIAA2012 KIAA2012 5.20E-03 2.16 TC1100007216.hg.1 PRRG4 proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) 7.43E-03 2.15 TC0400012977.hg.1 SH3D19
    [Show full text]
  • Interstitial Deletion at 11Q14.2-11Q22.1 May Cause
    Papoulidis et al. Molecular Cytogenetics (2015) 8:71 DOI 10.1186/s13039-015-0175-y CASE REPORT Open Access Interstitial deletion at 11q14.2-11q22.1 may cause severe learning difficulties, mental retardation and mild heart defects in 13-year old male Ioannis Papoulidis1*, Vassilis Paspaliaris1, Elisavet Siomou1, Sandro Orru2, Roberta Murru2, Stavros Sifakis3, Petros Nikolaidis4, Antonios Garas5, Sotirios Sotiriou5, Loretta Thomaidis6 and Emmanouil Manolakos1,2 Abstract Interstitial deletions of the long arm of chromosome 11 are rare, and they could be assumed as non-recurrent chromosomal rearrangements due to high variability of the size and the breakpoints of the deleted region. The exact region of the deletion was difficult to be determined before the use of molecular cytogenetic techniques such as array comparative genomic hybridization (aCGH). Here, a 13-year old boy with severe learning difficulties, mental retardation and mild heart defects is described. Conventional G-band karyotyping was performed and it is found that the patient is a carrier of a de novo interstitial deletion on the long arm of chromosome 11, involving 11q14 and 11q22 breakpoints. Further investigation, using aCGH, specified the deleted region to 11q14.2-11q22.1. There was a difficulty in correlating the genotype with the phenotype of the patient due to lack of similar cases in literature. More studies should be done in order to understand the genetic background that underlies the phenotypic differences observed in similar cases. Background Moreover, before the introduction of molecular cyto- Terminal deletions of the long arm of chromosome genetic approaches, the resolution efficiency provided 11 have been numerously described, and they are as- by conventional karyotype analysis jointly with the sym- sociated with Jacobsen syndrome (OMIM 147791) metric 11q banding pattern [3, 4], limited the accuracy and characterized by thrombocytopenia, mental re- of identification of breakpoints and precise deleted gen- tardation, short stature, congenital heart defect, and omic regions.
    [Show full text]
  • Prediction and Validation of Transcription Factors Modulating the Expression of Sestrin3 Gene Using an Integrated Computational and Experimental Approach
    RESEARCH ARTICLE Prediction and Validation of Transcription Factors Modulating the Expression of Sestrin3 Gene Using an Integrated Computational and Experimental Approach Rajneesh Srivastava1, Yang Zhang2, Xiwen Xiong2, Xiaoning Zhang2,3, Xiaoyan Pan2,4,X. Charlie Dong2, Suthat Liangpunsakul2,5,6*, Sarath Chandra Janga1,7,8* a11111 1 Department of Biohealth Informatics, School of Informatics and Computing, Indiana University Purdue University, 719 Indiana Ave Ste 319, Walker Plaza Building, Indianapolis, Indiana, 46202, United States of America, 2 Department of Biochemistry and Molecular Biology, 635 Barnhill Drive, Indianapolis, Indiana, 46202, United States of America, 3 Department of Clinical Laboratory, Shandong Provincial Qianfoshan Hospital, 16766 Jingshi Road, Jinan, Shandong Province, 250014, China, 4 Division of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, 325015, China, 5 Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University, Indianapolis, Indiana, 46202, United States of America, 6 Roudebush Veterans Affairs Administration Hospital, Indianapolis, Indiana, 46202, United States of America, 7 Center for Computational Biology and OPEN ACCESS Bioinformatics, Indiana University School of Medicine, 5021 Health Information and Translational Sciences Citation: Srivastava R, Zhang Y, Xiong X, Zhang X, (HITS), 410 West 10th Street, Indianapolis, Indiana, 46202, United States of America, 8 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Medical Research and Library Pan X, Dong XC, et al. (2016) Prediction and Building, 975 West Walnut Street, Indianapolis, Indiana, 46202, United States of America Validation of Transcription Factors Modulating the Expression of Sestrin3 Gene Using an Integrated * [email protected] (SL); [email protected] (SCJ) Computational and Experimental Approach.
    [Show full text]
  • PP1-Associated Signaling and − B/AP-1 Κ Inhibition of NF- Tolerance
    Downloaded from http://www.jimmunol.org/ by guest on October 3, 2021 is online at: average * and − B/AP-1 κ The Journal of Immunology published online 26 February 2014 from submission to initial decision 4 weeks from acceptance to publication http://www.jimmunol.org/content/early/2014/02/26/jimmun ol.1301610 Identification of Two Forms of TNF Tolerance in Human Monocytes: Differential Inhibition of NF- PP1-Associated Signaling Johannes Günther, Nico Vogt, Katharina Hampel, Rolf Bikker, Sharon Page, Benjamin Müller, Judith Kandemir, Michael Kracht, Oliver Dittrich-Breiholz, René Huber and Korbinian Brand J Immunol Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2014/02/26/jimmunol.130161 0.DCSupplemental Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of October 3, 2021. Published February 26, 2014, doi:10.4049/jimmunol.1301610 The Journal of Immunology Identification of Two Forms of TNF Tolerance in Human Monocytes: Differential Inhibition of NF-kB/AP-1– and PP1-Associated Signaling Johannes Gunther,*€ ,1 Nico Vogt,*,1 Katharina Hampel,*,1 Rolf Bikker,* Sharon Page,* Benjamin Muller,*€ Judith Kandemir,* Michael Kracht,† Oliver Dittrich-Breiholz,‡ Rene´ Huber,* and Korbinian Brand* The molecular basis of TNF tolerance is poorly understood.
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • Systems Genetics Identifies Sestrin 3 As a Regulator of a Proconvulsant Gene Network in Human Epileptic Hippocampus
    ARTICLE Received 1 Sep 2014 | Accepted 4 Dec 2014 | Published 23 Jan 2015 DOI: 10.1038/ncomms7031 Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus Michael R. Johnson1,y, Jacques Behmoaras2,*, Leonardo Bottolo3,*, Michelle L. Krishnan4,*, Katharina Pernhorst5,*, Paola L. Meza Santoscoy6,*, Tiziana Rossetti7, Doug Speed8, Prashant K. Srivastava1,7, Marc Chadeau-Hyam9, Nabil Hajji10, Aleksandra Dabrowska10, Maxime Rotival7, Banafsheh Razzaghi7, Stjepana Kovac11, Klaus Wanisch11, Federico W. Grillo7, Anna Slaviero7, Sarah R. Langley1,7, Kirill Shkura1,7, Paolo Roncon12,13, Tisham De7, Manuel Mattheisen14,15,16, Pitt Niehusmann5, Terence J. O’Brien17, Slave Petrovski18, Marec von Lehe19, Per Hoffmann20,21, Johan Eriksson22,23,24, Alison J. Coffey25, Sven Cichon20,21, Matthew Walker11, Michele Simonato12,13,26,Be´ne´dicte Danis27, Manuela Mazzuferi27, Patrik Foerch27, Susanne Schoch5,28, Vincenzo De Paola7, Rafal M. Kaminski27, Vincent T. Cunliffe6, Albert J. Becker5,y & Enrico Petretto7,29,y Gene-regulatory network analysis is a powerful approach to elucidate the molecular processes and pathways underlying complex disease. Here we employ systems genetics approaches to characterize the genetic regulation of pathophysiological pathways in human temporal lobe epilepsy (TLE). Using surgically acquired hippocampi from 129 TLE patients, we identify a gene-regulatory network genetically associated with epilepsy that contains a specialized, highly expressed transcriptional module encoding proconvulsive cytokines and Toll-like receptor signalling genes. RNA sequencing analysis in a mouse model of TLE using 100 epileptic and 100 control hippocampi shows the proconvulsive module is preserved across-species, specific to the epileptic hippocampus and upregulated in chronic epilepsy.
    [Show full text]
  • Polyclonal Antibody to Sestrin-3 (SESN3) (N-Term)
    AP09871PU-N OriGene Technologies Inc. OriGene EU Acris Antibodies GmbH 9620 Medical Center Drive, Ste 200 Schillerstr. 5 Rockville, MD 20850 32052 Herford UNITED STATES GERMANY Phone: +1-888-267-4436 Phone: +49-5221-34606-0 Fax: +1-301-340-8606 Fax: +49-5221-34606-11 [email protected] [email protected] Polyclonal Antibody to Sestrin-3 (SESN3) (N-term) - Aff - Purified Alternate names: SEST3 Catalog No.: AP09871PU-N Quantity: 0.1 mg Concentration: 0.70 mg/ml Background: Sestrin 3(SESN3), located at human chromosome 11q21, belongs to the sestrin family of proteins. These proteins are cystein sulfinyl reductases and they modulate peroxide signaling and antioxidant defense (1). This family of proteins is only present in multicellular organisms ranging from nematodes to mammals. These proteins selectively reduce or repair hyperoxidized forms of typical 2-Cys peroxiredoxins within eukaryotes (2). Peroxiredoxins are the enzymes that metabolize peroxides. Expression of these proteins is regulated by p53, a tumor suppressor protein (3). Sestrin 3 was identified as a forkhead box O (FoxO) target gene with antioxidant activity (4). Recently it was reported that sestrin 3 may play an important role in AKT induced increase in ROS and it might be a promising target in selectively killing cancer cells containing high levels of AKT activity (5). AKT is a protein kinase that is hyperactivated in cancer. This hyperactivity leads to an increase in intracellular ROS mainly by inhibiting the expression of ROS scavengers downstream of FoxO, such as sestrin 3 (4). This phenomenon was supported by the fact that AKT deficient cells contained high levels of sestrin 3 leading to low levels of ROS.
    [Show full text]
  • Supplementary Methods
    Supplementary Methods Patient Cohorts and Clinicopathological Review AOCS and Clinical Cohort AOCS is a population-based, case control study of ovarian cancer which recruited eligible women aged 18-79 years with newly diagnosed epithelial ovarian cancer (including primary peritoneal and fallopian tube cancer) through 20 gynaecologic oncology units across all Australian states, between January 2002 and June 2006. Women who were unable to provide informed consent due to illness, language difficulties or mental incapacity were excluded, as were those whose diagnosis was not histopathologically confirmed. Detailed clinical and follow-up data was obtained from medical records at predefined intervals: post surgery, post primary chemotherapy, at 6-monthly intervals to 5 years and annually thereafter. All treatment details and clinical assessments were recorded on case report forms using Good Clinical Practice (GCP) guidelines (ICH E6: Good Clinical Practice: Consolidated Guidance. 1996; http://www.fda.gov/oc/gcp/guidance.html), and included chemotherapy regimen, imaging details and pre- and post-treatment serum CA125 levels. The CA125 assay type and upper limit of normal for each measurement were recorded and assignment of relapse date was based on Gynecologic Cancer Intergroup (GCIG) criteria1. Clinical details for the cases from The Royal Brisbane Hospital, and Westmead Hospital were obtained retrospectively from medical records. The majority of patients with invasive ovarian cancer (n= 267) underwent laparotomy for diagnosis, staging and debulking and subsequently received first-line platinum/taxane based chemotherapy. In most cases, tumor examined was excised at the time of primary surgery, prior to the administration of chemotherapy. Eighteen patients who had neoadjuvant, platinum based chemotherapy were also included in the study as were 18 patients with low malignant potential disease.
    [Show full text]